Brief: Fate Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Highlights Operational Progress
28/02/2022 21:04
Feb 28 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS
* Q4 REVENUE $17.1 MILLION
* QTRLY LOSS PER SHARE $0.72
Source text for Eikon: ID:nGNX2M1Br3
Further company coverage: FATE.O
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview